Belgium's pharmaceutical industry faces growing fears as exports and investments steadily decline. Pharma director Caroline Ven warns that serious concern exists about coming years.
Biopharmaceutical investment has shrunk steadily for several years, while employment also weakened.
Pharmaceutical exports fell by six point eight percent during the last year. Drugmaker GSK announced plans to eliminate over twelve hundred jobs this October.
Researchers, universities, hospitals, and research centers could soon face serious negative consequences. Industry urges a strategy through its Life Sciences Declaration to strengthen biopharmaceuticals.